Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA ...
Alignment with FDA on Best Corrected Visual Acuity ≥ 15-Letter Loss as Primary Outcome Measure - Representing the Highest Value Outcome to Patients and Physicians
Source: eagletribune.com